China
· Delayed Price · Currency is CNY Yifeng Pharmacy Chain Statistics
Total Valuation
Yifeng Pharmacy Chain has a market cap or net worth of CNY 29.61 billion. The enterprise value is 28.59 billion.
| Market Cap | 29.61B |
| Enterprise Value | 28.59B |
Important Dates
The next estimated earnings date is Thursday, October 31, 2024.
| Earnings Date | Oct 31, 2024 |
| Ex-Dividend Date | Jun 7, 2024 |
Share Statistics
Yifeng Pharmacy Chain has 1.21 billion shares outstanding. The number of shares has decreased by -0.48% in one year.
| Shares Outstanding | 1.21B |
| Shares Change (YoY) | -0.48% |
| Shares Change (QoQ) | -1.92% |
| Owned by Insiders (%) | 14.22% |
| Owned by Institutions (%) | 21.39% |
| Float | 532.50M |
Valuation Ratios
The trailing PE ratio is 19.59 and the forward PE ratio is 18.50. Yifeng Pharmacy Chain's PEG ratio is 1.03.
| PE Ratio | 19.59 |
| Forward PE | 18.50 |
| PS Ratio | 1.25 |
| PB Ratio | 2.90 |
| P/FCF Ratio | 6.95 |
| PEG Ratio | 1.03 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.35, with an EV/FCF ratio of 6.71.
| EV / Earnings | 19.00 |
| EV / Sales | 1.21 |
| EV / EBITDA | 7.35 |
| EV / EBIT | 13.43 |
| EV / FCF | 6.71 |
Financial Position
The company has a current ratio of 1.22, with a Debt / Equity ratio of 0.52.
| Current Ratio | 1.22 |
| Quick Ratio | 0.85 |
| Debt / Equity | 0.52 |
| Debt / EBITDA | 1.44 |
| Debt / FCF | 1.32 |
| Interest Coverage | 11.61 |
Financial Efficiency
Return on equity (ROE) is 15.86% and return on invested capital (ROIC) is 8.92%.
| Return on Equity (ROE) | 15.86% |
| Return on Assets (ROA) | 5.60% |
| Return on Capital (ROIC) | 8.92% |
| Revenue Per Employee | 596,289 |
| Profits Per Employee | 37,944 |
| Employee Count | 39,652 |
| Asset Turnover | 0.99 |
| Inventory Turnover | 3.95 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -17.14% in the last 52 weeks. The beta is 0.27, so Yifeng Pharmacy Chain's price volatility has been lower than the market average.
| Beta (5Y) | 0.27 |
| 52-Week Price Change | -17.14% |
| 50-Day Moving Average | 20.34 |
| 200-Day Moving Average | 29.42 |
| Relative Strength Index (RSI) | 62.49 |
| Average Volume (20 Days) | 18,309,508 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Yifeng Pharmacy Chain had revenue of CNY 23.64 billion and earned 1.50 billion in profits. Earnings per share was 1.25.
| Revenue | 23.64B |
| Gross Profit | 8.98B |
| Operating Income | 2.13B |
| Pretax Income | 2.14B |
| Net Income | 1.50B |
| EBITDA | 2.34B |
| EBIT | 2.13B |
| Earnings Per Share (EPS) | 1.25 |
Balance Sheet
The company has 7.34 billion in cash and 5.62 billion in debt, giving a net cash position of 1.72 billion or 1.42 per share.
| Cash & Cash Equivalents | 7.34B |
| Total Debt | 5.62B |
| Net Cash | 1.72B |
| Net Cash Per Share | 1.42 |
| Equity (Book Value) | 10.91B |
| Book Value Per Share | 8.42 |
| Working Capital | 2.53B |
Cash Flow
In the last 12 months, operating cash flow was 5.04 billion and capital expenditures -776.22 million, giving a free cash flow of 4.26 billion.
| Operating Cash Flow | 5.04B |
| Capital Expenditures | -776.22M |
| Free Cash Flow | 4.26B |
| FCF Per Share | 3.51 |
Margins
Gross margin is 37.99%, with operating and profit margins of 9.00% and 6.36%.
| Gross Margin | 37.99% |
| Operating Margin | 9.00% |
| Pretax Margin | 9.04% |
| Profit Margin | 6.36% |
| EBITDA Margin | 9.90% |
| EBIT Margin | 9.00% |
| FCF Margin | 18.02% |
Dividends & Yields
This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 2.02%.
| Dividend Per Share | 0.50 |
| Dividend Yield | 2.02% |
| Dividend Growth (YoY) | 50.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 32.13% |
| Buyback Yield | 0.48% |
| Shareholder Yield | 2.49% |
| Earnings Yield | 5.11% |
| FCF Yield | 14.39% |
Stock Splits
The last stock split was on June 7, 2024. It was a forward split with a ratio of 1.2.
| Last Split Date | Jun 7, 2024 |
| Split Type | Forward |
| Split Ratio | 1.2 |
Scores
Yifeng Pharmacy Chain has an Altman Z-Score of 3.06.
| Altman Z-Score | 3.06 |
| Piotroski F-Score | n/a |